{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:58:02Z","timestamp":1794369482292,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Vpu is a multifunctional accessory protein that enhances the release of HIV-1 by counteracting the entrapment of nascent virions on infected cell surface mediated by BST2\/Tetherin. Vpu-mediated BST2 antagonism involves physical association with BST2 and subsequent mislocalization of the restriction factor to intracellular compartments followed by SCF(\u03b2-TrCP) E3 ligase-dependent lysosomal degradation. Apart from BST2 antagonism, Vpu also induces down regulation of several immune molecules, including CD4 and SLAMF6\/NTB-A, to evade host immune responses and promote viral dissemination. However, it should be noted that the multiple functions of Vpu have been studied in cell-based assays, and thus it remains unclear how Vpu influences the dynamic of HIV-1 infection in <jats:italic>in vivo<\/jats:italic> conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Using a humanized mouse model of acute infection as well as CCR5-tropic HIV-1 that lack Vpu or encode WT Vpu or Vpu with mutations in the \u03b2-TrCP binding domain, we provide evidence that Vpu-mediated BST2 antagonism plays a crucial role in establishing early plasma viremia and viral dissemination. Interestingly, we also find that efficient HIV-1 release and dissemination are directly related to functional strength of Vpu in antagonizing BST2. Thus, reduced antagonism of BST2 due to \u03b2-TrCP binding domain mutations results in decreased plasma viremia and frequency of infected T cells, highlighting the importance of Vpu-mediated \u03b2-TrCP-dependent BST-2 degradation for optimal initial viral propagation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Overall, our findings suggest that BST2 antagonism by Vpu is critical for efficient early viral expansion and dissemination during acute infection and as such is likely to confer HIV-1 increased transmission fitness.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-10-128","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T12:01:23Z","timestamp":1383739283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice"],"prefix":"10.1186","volume":"10","author":[{"given":"Vibhuti P","family":"Dave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mame Massar","family":"Dieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric A","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"3619_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.immuni.2012.08.013","volume":"37","author":"D Blanco-Melo","year":"2012","unstructured":"Blanco-Melo D, Venkatesh S, Bieniasz PD: Intrinsic cellular defenses against human immunodeficiency viruses. Immunity. 2012, 37: 399-411. 10.1016\/j.immuni.2012.08.013.","journal-title":"Immunity"},{"key":"3619_CR2","doi-asserted-by":"publisher","first-page":"40875","DOI":"10.1074\/jbc.R112.416925","volume":"287","author":"RS Harris","year":"2012","unstructured":"Harris RS, Hultquist JF, Evans DT: The restriction factors of human immunodeficiency virus. J Biol Chem. 2012, 287: 40875-40883. 10.1074\/jbc.R112.416925.","journal-title":"J Biol Chem"},{"key":"3619_CR3","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.177.5.3260","volume":"177","author":"AL Blasius","year":"2006","unstructured":"Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M: Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol. 2006, 177: 3260-3265.","journal-title":"J Immunol"},{"key":"3619_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJ Neil","year":"2008","unstructured":"Neil SJ, Zang T, Bieniasz PD: Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008, 451: 425-430. 10.1038\/nature06553.","journal-title":"Nature"},{"key":"3619_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","volume":"3","author":"N Van Damme","year":"2008","unstructured":"Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J: The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008, 3: 245-252. 10.1016\/j.chom.2008.03.001.","journal-title":"Cell Host Microbe"},{"key":"3619_CR6","doi-asserted-by":"publisher","first-page":"e1002456","DOI":"10.1371\/journal.ppat.1002456","volume":"7","author":"M Lehmann","year":"2011","unstructured":"Lehmann M, Rocha S, Mangeat B, Blanchet F, Uji IH, Hofkens J, Piguet V: Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog. 2011, 7: e1002456-10.1371\/journal.ppat.1002456.","journal-title":"PLoS Pathog"},{"key":"3619_CR7","doi-asserted-by":"publisher","first-page":"e1003483","DOI":"10.1371\/journal.ppat.1003483","volume":"9","author":"S Venkatesh","year":"2013","unstructured":"Venkatesh S, Bieniasz PD: Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog. 2013, 9: e1003483-10.1371\/journal.ppat.1003483.","journal-title":"PLoS Pathog"},{"key":"3619_CR8","doi-asserted-by":"publisher","first-page":"e1000955","DOI":"10.1371\/journal.ppat.1000955","volume":"6","author":"N Casartelli","year":"2010","unstructured":"Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O: Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog. 2010, 6: e1000955-10.1371\/journal.ppat.1000955.","journal-title":"PLoS Pathog"},{"key":"3619_CR9","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1128\/JVI.01447-10","volume":"84","author":"C Jolly","year":"2010","unstructured":"Jolly C, Booth NJ, Neil SJ: Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin\/BST-2-mediated restriction in T cells. J Virol. 2010, 84: 12185-12199. 10.1128\/JVI.01447-10.","journal-title":"J Virol"},{"key":"3619_CR10","doi-asserted-by":"publisher","first-page":"e1002596","DOI":"10.1371\/journal.ppat.1002596","volume":"8","author":"BS Barrett","year":"2012","unstructured":"Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, Santiago ML: A single nucleotide polymorphism in\u2009<\u2009italic\u2009>\u2009tetherin<\/italic\u2009>\u2009promotes retrovirus restriction\u2009<\u2009italic\u2009>\u2009in vivo<\/italic>. PLoS Pathog. 2012, 8: e1002596-10.1371\/journal.ppat.1002596.","journal-title":"PLoS Pathog"},{"key":"3619_CR11","doi-asserted-by":"publisher","first-page":"18097","DOI":"10.1073\/pnas.1113694108","volume":"108","author":"RA Liberatore","year":"2011","unstructured":"Liberatore RA, Bieniasz PD: Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci U S A. 2011, 108: 18097-18101. 10.1073\/pnas.1113694108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3619_CR12","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.1128\/JVI.01699-10","volume":"84","author":"R Vigan","year":"2010","unstructured":"Vigan R, Neil SJ: Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol. 2010, 84: 12958-12970. 10.1128\/JVI.01699-10.","journal-title":"J Virol"},{"key":"3619_CR13","doi-asserted-by":"publisher","first-page":"e1003299","DOI":"10.1371\/journal.ppat.1003299","volume":"9","author":"MW McNatt","year":"2013","unstructured":"McNatt MW, Zang T, Bieniasz PD: Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog. 2013, 9: e1003299-10.1371\/journal.ppat.1003299.","journal-title":"PLoS Pathog"},{"key":"3619_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1074\/jbc.M111.296772","volume":"287","author":"M Skasko","year":"2012","unstructured":"Skasko M, Wang Y, Tian Y, Tokarev A, Munguia J, Ruiz A, Stephens EB, Opella SJ, Guatelli J: HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J Biol Chem. 2012, 287: 58-67. 10.1074\/jbc.M111.296772.","journal-title":"J Biol Chem"},{"key":"3619_CR15","doi-asserted-by":"publisher","first-page":"e1000450","DOI":"10.1371\/journal.ppat.1000450","volume":"5","author":"RS Mitchell","year":"2009","unstructured":"Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC: Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 2009, 5: e1000450-10.1371\/journal.ppat.1000450.","journal-title":"PLoS Pathog"},{"key":"3619_CR16","doi-asserted-by":"publisher","first-page":"e1000856","DOI":"10.1371\/journal.ppat.1000856","volume":"6","author":"M Dube","year":"2010","unstructured":"Dube M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, Chiasson A, Cohen EA: Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 2010, 6: e1000856-10.1371\/journal.ppat.1000856.","journal-title":"PLoS Pathog"},{"key":"3619_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/j.1600-0854.2011.01277.x","volume":"12","author":"M Dube","year":"2011","unstructured":"Dube M, Paquay C, Roy BB, Bego MG, Mercier J, Cohen EA: HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic. 2011, 12: 1714-1729. 10.1111\/j.1600-0854.2011.01277.x.","journal-title":"Traffic"},{"key":"3619_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-4690-7-51","volume":"7","author":"H Hauser","year":"2010","unstructured":"Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM: HIV-1 Vpu and HIV-2 Env counteract BST-2\/tetherin by sequestration in a perinuclear compartment. Retrovirology. 2010, 7: 51-10.1186\/1742-4690-7-51.","journal-title":"Retrovirology"},{"key":"3619_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1097-2765(00)80056-8","volume":"1","author":"F Margottin","year":"1998","unstructured":"Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R: A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell. 1998, 1: 565-574. 10.1016\/S1097-2765(00)80056-8.","journal-title":"Mol Cell"},{"key":"3619_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/JVI.01795-10","volume":"85","author":"AA Tokarev","year":"2011","unstructured":"Tokarev AA, Munguia J, Guatelli JC: Serine-threonine ubiquitination mediates downregulation of BST-2\/tetherin and relief of restricted virion release by HIV-1 Vpu. J Virol. 2011, 85: 51-63. 10.1128\/JVI.01795-10.","journal-title":"J Virol"},{"key":"3619_CR21","doi-asserted-by":"publisher","first-page":"14837","DOI":"10.1074\/jbc.M112.349928","volume":"287","author":"JK Gustin","year":"2012","unstructured":"Gustin JK, Douglas JL, Bai Y, Moses AV: Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain. J Biol Chem. 2012, 287: 14837-14850. 10.1074\/jbc.M112.349928.","journal-title":"J Biol Chem"},{"key":"3619_CR22","doi-asserted-by":"publisher","first-page":"e1000843","DOI":"10.1371\/journal.ppat.1000843","volume":"6","author":"C Pardieu","year":"2010","unstructured":"Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, Bieniasz P, Kellam P, Towers GJ, Neil SJ: The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 2010, 6: e1000843-10.1371\/journal.ppat.1000843.","journal-title":"PLoS Pathog"},{"key":"3619_CR23","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1128\/JVI.00242-09","volume":"83","author":"JL Douglas","year":"2009","unstructured":"Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV: Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2\/Tetherin via a {beta}TrCP-dependent mechanism. J Virol. 2009, 83: 7931-7947. 10.1128\/JVI.00242-09.","journal-title":"J Virol"},{"key":"3619_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4690-8-9","volume":"8","author":"HM Tervo","year":"2011","unstructured":"Tervo HM, Homann S, Ambiel I, Fritz JV, Fackler OT, Keppler OT: beta-TrCP is dispensable for Vpu\u2019s ability to overcome the CD317\/Tetherin-imposed restriction to HIV-1 release. Retrovirology. 2011, 8: 9-10.1186\/1742-4690-8-9.","journal-title":"Retrovirology"},{"key":"3619_CR25","doi-asserted-by":"publisher","first-page":"e1002609","DOI":"10.1371\/journal.ppat.1002609","volume":"8","author":"T Kueck","year":"2012","unstructured":"Kueck T, Neil SJ: A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog. 2012, 8: e1002609-10.1371\/journal.ppat.1002609.","journal-title":"PLoS Pathog"},{"key":"3619_CR26","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1128\/JVI.01549-09","volume":"84","author":"C Goffinet","year":"2010","unstructured":"Goffinet C, Homann S, Ambiel I, Tibroni N, Rupp D, Keppler OT, Fackler OT: Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J Virol. 2010, 84: 4089-4094. 10.1128\/JVI.01549-09.","journal-title":"J Virol"},{"key":"3619_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-7-1","volume":"7","author":"M Schindler","year":"2010","unstructured":"Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F: Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology. 2010, 7: 1-10.1186\/1742-4690-7-1.","journal-title":"Retrovirology"},{"key":"3619_CR28","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/JVI.01800-08","volume":"83","author":"M Dube","year":"2009","unstructured":"Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA: Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol. 2009, 83: 4574-4590. 10.1128\/JVI.01800-08.","journal-title":"J Virol"},{"key":"3619_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1742-4690-4-75","volume":"4","author":"J Binette","year":"2007","unstructured":"Binette J, Dube M, Mercier J, Halawani D, Latterich M, Cohen EA: Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology. 2007, 4: 75-10.1186\/1742-4690-4-75.","journal-title":"Retrovirology"},{"key":"3619_CR30","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1128\/jvi.66.12.7193-7200.1992","volume":"66","author":"RL Willey","year":"1992","unstructured":"Willey RL, Maldarelli F, Martin MA, Strebel K: Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol. 1992, 66: 7193-7200.","journal-title":"J Virol"},{"key":"3619_CR31","doi-asserted-by":"publisher","first-page":"e1000869","DOI":"10.1371\/journal.ppat.1000869","volume":"6","author":"JG Magadan","year":"2010","unstructured":"Magadan JG, Perez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS: Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6: e1000869-10.1371\/journal.ppat.1000869.","journal-title":"PLoS Pathog"},{"key":"3619_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0960-9822(99)80284-X","volume":"9","author":"J Lama","year":"1999","unstructured":"Lama J, Mangasarian A, Trono D: Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol. 1999, 9: 622-631. 10.1016\/S0960-9822(99)80284-X.","journal-title":"Curr Biol"},{"key":"3619_CR33","doi-asserted-by":"publisher","first-page":"28346","DOI":"10.1074\/jbc.M300327200","volume":"278","author":"K Levesque","year":"2003","unstructured":"Levesque K, Zhao YS, Cohen EA: Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem. 2003, 278: 28346-28353. 10.1074\/jbc.M300327200.","journal-title":"J Biol Chem"},{"key":"3619_CR34","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.1128\/JVI.00252-06","volume":"80","author":"S Wildum","year":"2006","unstructured":"Wildum S, Schindler M, Munch J, Kirchhoff F: Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol. 2006, 80: 8047-8059. 10.1128\/JVI.00252-06.","journal-title":"J Virol"},{"key":"3619_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.chom.2010.10.008","volume":"8","author":"AH Shah","year":"2010","unstructured":"Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E: Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe. 2010, 8: 397-409. 10.1016\/j.chom.2010.10.008.","journal-title":"Cell Host Microbe"},{"key":"3619_CR36","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1128\/JVI.05788-11","volume":"86","author":"G Matusali","year":"2012","unstructured":"Matusali G, Potesta M, Santoni A, Cerboni C, Doria M: The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol. 2012, 86: 4496-4504. 10.1128\/JVI.05788-11.","journal-title":"J Virol"},{"key":"3619_CR37","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1128\/JVI.07062-11","volume":"86","author":"K Sato","year":"2012","unstructured":"Sato K, Misawa N, Fukuhara M, Iwami S, An DS, Ito M, Koyanagi Y: Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol. 2012, 86: 5000-5013. 10.1128\/JVI.07062-11.","journal-title":"J Virol"},{"key":"3619_CR38","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1086\/655657","volume":"202","author":"JJ Chang","year":"2010","unstructured":"Chang JJ, Altfeld M: Innate immune activation in primary HIV-1 infection. J Infect Dis. 2010, 202: S297-S301. 10.1086\/655657.","journal-title":"J Infect Dis"},{"key":"3619_CR39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1128\/JVI.01629-06","volume":"81","author":"M Sourisseau","year":"2007","unstructured":"Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O: Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol. 2007, 81: 1000-1012. 10.1128\/JVI.01629-06.","journal-title":"J Virol"},{"key":"3619_CR40","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/JVI.00381-07","volume":"81","author":"P Chen","year":"2007","unstructured":"Chen P, Hubner W, Spinelli MA, Chen BK: Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007, 81: 12582-12595. 10.1128\/JVI.00381-07.","journal-title":"J Virol"},{"key":"3619_CR41","doi-asserted-by":"publisher","first-page":"e53138","DOI":"10.1371\/journal.pone.0053138","volume":"8","author":"P Zhong","year":"2013","unstructured":"Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W: Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. PLoS One. 2013, 8: e53138-10.1371\/journal.pone.0053138.","journal-title":"PLoS One"},{"key":"3619_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-4690-8-26","volume":"8","author":"CM Coleman","year":"2011","unstructured":"Coleman CM, Spearman P, Wu L: Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology. 2011, 8: 26-10.1186\/1742-4690-8-26.","journal-title":"Retrovirology"},{"key":"3619_CR43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.chom.2012.10.007","volume":"12","author":"RP Galao","year":"2012","unstructured":"Galao RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ: Innate sensing of HIV-1 assembly by tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe. 2012, 12: 633-644. 10.1016\/j.chom.2012.10.007.","journal-title":"Cell Host Microbe"},{"key":"3619_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/156652407780059177","volume":"7","author":"OW Lindwasser","year":"2007","unstructured":"Lindwasser OW, Chaudhuri R, Bonifacino JS: Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med. 2007, 7: 171-184. 10.2174\/156652407780059177.","journal-title":"Curr Mol Med"},{"key":"3619_CR45","doi-asserted-by":"publisher","first-page":"e1003093","DOI":"10.1371\/journal.ppat.1003093","volume":"8","author":"D Sauter","year":"2012","unstructured":"Sauter D, Unterweger D, Vogl M, Usmani SM, Heigele A, Kluge SF, Hermkes E, Moll M, Barker E, Peeters M, et al: Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog. 2012, 8: e1003093-10.1371\/journal.ppat.1003093.","journal-title":"PLoS Pathog"},{"key":"3619_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.chom.2009.10.004","volume":"6","author":"D Sauter","year":"2009","unstructured":"Sauter D, Schindler M, Specht A, Landford WN, Munch J, Kim KA, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, et al: Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe. 2009, 6: 409-421. 10.1016\/j.chom.2009.10.004.","journal-title":"Cell Host Microbe"},{"key":"3619_CR47","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1128\/JVI.06971-11","volume":"86","author":"MG Bego","year":"2012","unstructured":"Bego MG, Mercier J, Cohen EA: Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling. J Virol. 2012, 86: 3513-3527. 10.1128\/JVI.06971-11.","journal-title":"J Virol"},{"key":"3619_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","volume":"10","author":"GB Cohen","year":"1999","unstructured":"Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D: The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 1999, 10: 661-671. 10.1016\/S1074-7613(00)80065-5.","journal-title":"Immunity"},{"key":"3619_CR49","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1084\/jem.187.7.1103","volume":"187","author":"RA Subbramanian","year":"1998","unstructured":"Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, Bergeron D, Cohen EA: Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med. 1998, 187: 1103-1111. 10.1084\/jem.187.7.1103.","journal-title":"J Exp Med"},{"key":"3619_CR50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/jvi.64.2.621-629.1990","volume":"64","author":"T Klimkait","year":"1990","unstructured":"Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM: The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol. 1990, 64: 621-629.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:15:27Z","timestamp":1630548927000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-10-128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-10-128","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,6]]},"assertion":[{"value":"27 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"128"}}